Arama Sonuçları - Tomoki Uchiyama

  • Gösterilen 1 - 3 sonuçlar arası kayıtlar. 3
Sonuçları Daraltın
  1. 1
    Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease

    Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease Yazar: Hiroshi Kawabata, Naohisa Tomosugi, Junya Kanda, Yasuhiro Tanaka, Kazuyuki Yoshizaki, Tomoki Uchiyama

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus

    Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus Yazar: Tomohide Hori, Tomoki Uchiyama, Mitsuru Tsudo, H Umadome, Hiroshi Ohno, Shizuko Fukuhara, K. Kita, Haruto Uchino

    Baskı/Yayın Bilgisi 1987
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling.

    Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling. Yazar: Nobuyoshi Arima, M Kamio, Kazunori Imada, Tomohide Hori, Takamitsu Hattori, Mitsuru Tsudo, M Okuma, Tomoki Uchiyama

    Baskı/Yayın Bilgisi 1992
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: